|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 34466 |
FusionGeneSummary for SLC39A8_GLS |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SLC39A8_GLS | Fusion gene ID: 34466 | Hgene | Tgene | Gene symbol | SLC39A8 | GLS | Gene ID | 64116 | 27165 |
| Gene name | solute carrier family 39 member 8 | glutaminase 2 | |
| Synonyms | BIGM103|CDG2N|LZT-Hs6|PP3105|ZIP8 | GA|GLS|LGA|hLGA | |
| Cytomap | 4q24 | 12q13.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | zinc transporter ZIP8BCG induced integral membrane protein BIGM103BCG-induced integral membrane protein in monocyte clone 103 proteinLIV-1 subfamily of ZIP zinc transporter 6ZIP-8Zrt- and Irt-like protein 8solute carrier family 39 (metal ion transpo | glutaminase liver isoform, mitochondrialL-glutamine amidohydrolasebreast cell glutaminaseglutaminase 2 (liver, mitochondrial)glutaminase Iphosphate-activated glutaminasephosphate-dependent glutaminase | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | Q9C0K1 | O94925 | |
| Ensembl transtripts involved in fusion gene | ENST00000424970, ENST00000394833, ENST00000356736, ENST00000510255, | ENST00000320717, ENST00000338435, ENST00000409626, ENST00000409428, ENST00000409215, ENST00000471443, | |
| Fusion gene scores | * DoF score | 3 X 3 X 3=27 | 8 X 7 X 3=168 |
| # samples | 3 | 8 | |
| ** MAII score | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(8/168*10)=-1.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: SLC39A8 [Title/Abstract] AND GLS [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | AW999094 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000424970 | ENST00000320717 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-3UTR | ENST00000424970 | ENST00000338435 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000424970 | ENST00000409626 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000424970 | ENST00000409428 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000424970 | ENST00000409215 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000424970 | ENST00000471443 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000394833 | ENST00000320717 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-3UTR | ENST00000394833 | ENST00000338435 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000394833 | ENST00000409626 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000394833 | ENST00000409428 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000394833 | ENST00000409215 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000394833 | ENST00000471443 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000356736 | ENST00000320717 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-3UTR | ENST00000356736 | ENST00000338435 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000356736 | ENST00000409626 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000356736 | ENST00000409428 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000356736 | ENST00000409215 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000356736 | ENST00000471443 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000510255 | ENST00000320717 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-3UTR | ENST00000510255 | ENST00000338435 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000510255 | ENST00000409626 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000510255 | ENST00000409428 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000510255 | ENST00000409215 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
| intron-intron | ENST00000510255 | ENST00000471443 | SLC39A8 | chr4 | 103183326 | - | GLS | chr2 | 191798952 | - |
Top |
FusionProtFeatures for SLC39A8_GLS |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| SLC39A8 | GLS |
| Acts as a manganese and zinc influx transporter(PubMed:12504855, PubMed:26637978). Plays a role in manganesereabsorption in the proximal tubule of the kidney and in manganeseuptake into the brain (PubMed:26637978).{ECO:0000269|PubMed:12504855, ECO:0000305|PubMed:26637978}. | Catalyzes the first reaction in the primary pathway forthe renal catabolism of glutamine. Plays a role in maintainingacid-base homeostasis. Regulates the levels of theneurotransmitter glutamate in the brain. Isoform 2 lacks catalyticactivity. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SLC39A8_GLS |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for SLC39A8_GLS |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SLC39A8_GLS |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Tgene | GLS | O94925 | DB00142 | Glutamic Acid | Glutaminase kidney isoform, mitochondrial | small molecule | approved|nutraceutical |
Top |
RelatedDiseases for SLC39A8_GLS |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | SLC39A8 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Hgene | SLC39A8 | C4225234 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn | 1 | ORPHANET;UNIPROT |
| Tgene | GLS | C0000786 | Spontaneous abortion | 1 | CTD_human |
| Tgene | GLS | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Tgene | GLS | C0029408 | Degenerative polyarthritis | 1 | CTD_human |
| Tgene | GLS | C0036341 | Schizophrenia | 1 | PSYGENET |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|